CytomX and Moderna Announce Strategic Research Collaboration for mRNA-Based Conditionally Activated Therapeutics
Go back to CytomX and Moderna Announce Strategic Research Collaboration for mRNA-Based Conditionally Activated Therapeutics| Eaton Vance Dividend Builder Fd Cl C (NASDAQ: CTMX) | Delayed: 3.81 -0.01 (0.26%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.82 | 52 Week High | $24.68 | |||
| Open | $3.76 | 52 Week Low | $9.10 | |||
| Day High | $3.89 | P/E | N/A | |||
| Day Low | $3.70 | EPS | $0.00 | |||
| Volume | 3,200,182 | |||||
| Marina Biotech, Inc. (NASDAQ: MRNA) | Delayed: 81.80 +2.04 (2.56%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $79.76 | 52 Week High | $0.52 | |||
| Open | $78.55 | 52 Week Low | $0.08 | |||
| Day High | $85.60 | P/E | N/A | |||
| Day Low | $77.50 | EPS | $-3.80 | |||
| Volume | 17,293,974 | |||||
